ENVB ENVB

Enveric Biosciences Stock Price

0.6265
-0.0051 (-0.81%)
0.6265
Volume 535,868
Bid Price 0.6265
Ask Price 0.627
News -
Day High 0.62

Low
0.55

52 Week Range

High
7.00

Day Low 0.55
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Enveric Biosciences Inc ENVB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0051 -0.81% 0.6265 18:56:06
Open Price Low Price High Price Close Price Prev Close
0.60 0.55 0.62 0.62 0.6316
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,288 535,868 $ 0.596435 $ 319,610 - 0.55 - 7.00
Last Trade Time Type Quantity Stock Price Currency
18:56:06 formt 1,500 $ 0.6265 USD

Period:

Draw Mode:

Enveric Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 20.41M 32.58M 30.28M $ - $ - -3.41 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 4.03M 23.60%

more financials information »

Enveric Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENVB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.750.75070.550.6690157322,287-0.1235-16.47%
1 Month1.061.120.550.8773148625,691-0.4335-40.9%
3 Months1.7752.250.551.38798,437-1.15-64.7%
6 Months1.963.740.552.402,280,658-1.33-68.04%
1 Year4.047.000.553.393,225,471-3.41-84.49%
3 Years5.807.000.553.423,111,519-5.17-89.2%
5 Years5.807.000.553.423,111,519-5.17-89.2%

Enveric Biosciences Description

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).


Your Recent History
NASDAQ
ENVB
Enveric Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.